Health Law & Business News

Moderna Phase 2 Study to Enroll 600, Phase 3 Expected in July

May 29, 2020, 8:59 PM

Moderna says first participants have been dosed in the company’s Phase 2 study of its covid-19 vaccine candidate.

  • Phase 2 expected to enroll 600 participants
  • Company is finalizing protocol for Phase 3 study, which is expected to begin in July

To view the source of this information click here

To contact the reporter on this story:
Linly Lin in San Francisco at llin153@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

To read more articles log in. To learn more about a subscription click here.